Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Crit Care Med. 2023 Dec 1;51(12):1790-1801. doi: 10.1097/CCM.0000000000006027. Epub 2023 Aug 28.
Extracorporeal membrane oxygenation (ECMO) is an advanced treatment for acute severe respiratory failure. Patients on ECMO are frequently maintained sedated and immobilized until weaning from ECMO, first, and then from mechanical ventilation. Avoidance of sedation and invasive ventilation during ECMO may have potential advantages. We performed a systematic literature review to assess efficacy and safety of awake ECMO without invasive ventilation in patients with respiratory failure.
PubMed, Web of Science, and Scopus were searched for studies reporting outcome of awake ECMO for adult patients with respiratory failure.
We included all studies reporting outcome of awake ECMO in patients with respiratory failure. Studies on ECMO for cardiovascular failure, cardiac arrest, or perioperative support and studies on pediatric patients were excluded. Two investigators independently screened and selected studies for inclusion.
Two investigators abstracted data on study characteristics, rate of awake ECMO failure, and mortality. Primary outcome was rate of awake ECMO failure (need for intubation). Pooled estimates with corresponding 95% CIs were calculated. Subgroup analyses by setting were performed.
A total of 57 studies (28 case reports) included data from 467 awake ECMO patients. The subgroup of patients with acute respiratory distress syndrome showed a pooled estimate for awake ECMO failure of 39.3% (95% CI, 24.0-54.7%), while in patients bridged to lung transplantation, pooled estimate was 23.4% (95% CI, 13.3-33.5%). Longest follow-up mortality was 121 of 439 (pooled estimate, 28%; 95% CI, 22.3-33.6%). Mortality in patients who failed awake ECMO strategy was 43 of 74 (pooled estimate, 57.2%; 95% CI, 40.2-74.3%). Two cases of cannula self-removal were reported.
Awake ECMO is feasible in selected patients, although the effect on outcome remains to be demonstrated. Mortality is almost 60% in patients who failed awake ECMO strategy.
体外膜肺氧合(ECMO)是急性严重呼吸衰竭的一种高级治疗方法。接受 ECMO 的患者通常在撤机和机械通气之前进行镇静和固定,首先是 ECMO,然后是机械通气。在 ECMO 期间避免镇静和有创通气可能具有潜在优势。我们进行了系统文献综述,以评估在呼吸衰竭患者中不进行有创通气的清醒 ECMO 的疗效和安全性。
PubMed、Web of Science 和 Scopus 搜索了关于呼吸衰竭成人患者清醒 ECMO 结果的研究报告。
我们纳入了所有报告呼吸衰竭患者清醒 ECMO 结果的研究。排除了心血管衰竭、心脏骤停或围手术期支持的 ECMO 研究以及儿科患者的研究。两名研究人员独立筛选并选择纳入的研究。
两名研究人员提取了研究特征、清醒 ECMO 失败率和死亡率的数据。主要结局为清醒 ECMO 失败率(需要插管)。计算了具有相应 95%置信区间的汇总估计值。按设置进行了亚组分析。
共有 57 项研究(28 项病例报告)纳入了 467 例清醒 ECMO 患者的数据。急性呼吸窘迫综合征患者亚组的清醒 ECMO 失败率汇总估计值为 39.3%(95%CI,24.0-54.7%),而在桥接肺移植的患者中,汇总估计值为 23.4%(95%CI,13.3-33.5%)。最长随访死亡率为 439 例中的 121 例(汇总估计值,28%;95%CI,22.3-33.6%)。清醒 ECMO 策略失败患者的死亡率为 74 例中的 43 例(汇总估计值,57.2%;95%CI,40.2-74.3%)。有两例报告了套管自行脱落。
在选定的患者中,清醒 ECMO 是可行的,尽管其对结局的影响仍有待证明。在清醒 ECMO 策略失败的患者中,死亡率接近 60%。